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Abstract
Background: Obesity has been longitudinally associated with depression but only few studies take a life course
approach. This longitudinal study investigates whether being overweight or obese at age 8 and 13 years is
associated with depressive symptoms more than 60 years later and whether this association is independent of late-
life body mass index (BMI). We also investigated the association of being overweight/obese at age 8 or 13 years
with ever having major depressive disorder (lifetime MDD).
Method: This analysis is based on a sub-sample of 889 AGES-Reykjavik participants with measured BMI data from
early life. Late-life depressive symptoms were measured with the Geriatric Depression Scale (GDS) and lifetime MDD
was assessed at late-life using the Mini International Neuropsychiatric Interview. Logistic regression analysis was
used to estimate the relationships between BMI (continuous and categorical) at age 8 or 13 years, and late-life
depressive symptoms (measured as GDS ≥ 5) or lifetime MDD, adjusted for sex, education, physical activity, smoking
status and alcohol use. In a separate model, additional adjustments were made for late-life BMI.
Results: One hundred and one subjects (11%) had depressive symptoms at late-life (GDS ≥ 5), and 39 subjects
(4.4%) had lifetime MDD. Being overweight or obese at age 8 or 13 years was not associated with higher depressive
symptoms during late-life, irrespective of late-life BMI. Being overweight or obese at age 8 years, but not age 13
years was associated with an increased risk of lifetime MDD (Odds Ratio (OR) (95% confidence interval [CI]) for age
8 = 4.03[1.16–13.96]P = 0.03 and age 13 = 2.65[0.69–10.26] P = 0.16, respectively).
Conclusion: Being overweight in childhood was associated with increased odds of lifetime MDD, although the
magnitude of the risk is uncertain given the small numbers of participants with lifetime MDD. No clear association
was observed between childhood and adolescent overweight/obesity and late-life depressive symptoms
irrespective of late life BMI.
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Introduction
The prevalence of children with overweight and obesity is
increasing. In developed countries, the age-standardized
prevalence in children and adolescents (ages 2–19 years)
has increased from 16.9% in 1980 to 23.8% in 2013 for
boys and 16.2 to 22.6% for girls [1]. Studies which take a
life course approach have suggested that early-life obesity
can lead to poorer later-life health outcomes including an
increased risk for cancer [2], diabetes [3], hypertension [4]
and cardiovascular disease mortality [5]. Hence having
obesity during childhood is a potential risk factor for adult
morbidity. Several studies have focused on the link be-
tween adolescent with obesity and mental health during
early or middle adult life [6–9] as adolescence is an im-
portant developmental period where appearances and peer
approval are key values. Increased body dissatisfaction,
low self-esteem and perceived stigmatization due to obes-
ity are hypothesized to increase the risk of psychiatric dis-
orders and in particular, depression [10, 11]. An
alternative explanation is a shared genetic risk, which has
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been suggested as a factor linking obesity and depression
[12].
Despite several studies [6, 8, 9, 13] examining the rela-
tionship between adolescent with obesity and depression
uncertainties remain, such as whether the relationship is
age-dependent. Studies examining children with obesity
(obesity under the age of 12y) and depression at adoles-
cence and adulthood have found inconsistent results (9,
14,-16). For example, two studies found that childhood
overweight/obesity is associated with an increased risk of
mood disorders in adulthood [9, 14], while others found
no association [15] or found inconsistent associations at
different childhood ages [16]. Furthermore, few studies
have a long enough follow-up to study the association
between childhood obesity with depression over the
whole life course. The influence of having overweight in
early-life on late-life mental health was investigated by
Martinson et al.(2016) who found that adolescent girls
with overweight (but not boys) had a 1.74 greater odds
of experiencing depression symptoms at age 65 than
their normal weight counterparts [6]. This study was
limited by the use of estimated body weight extrapolated
from high school photographs. Additionally, this and
many other studies did not consider that having over-
weight during childhood is largely predictive of having
overweight and obese during adulthood [17]. How much
the observed relationship between early-life weight and
later-life depression is explained by obesity at later life is
currently unknown.
The purpose of this study was to investigate the asso-
ciation between measured body mass index (BMI) in
childhood/ early adolescence and its relationship with
depression over a lifetime. The significance of this study
is its long-term follow-up enabling us to adopt a life-
course approach to weight and depression. The follow-
ing questions were addressed [1] Is BMI in childhood
(age 8 years) and adolescence (age 13 years) related to
late-life depressive symptoms (measured at age ~ 75y)?
[2] Is BMI in childhood and adolescence related to late-
life depressive symptoms irrespective of late-life BMI?
[3] Is BMI in childhood and adolescence related to life-
time MDD (~ 65 years follow-up)?
Method
Study population
The AGES-Reykjavik (Age, Gene/Environment Susceptibil-
ity) cohort is drawn from a random selection of survivors
from the established population-based cohort, the Reykjavik
Study (1967–1991) (n = 19,381). The Reykjavik study is a
cohort of men and women born between 1907 and 1935
that has been followed in Iceland since 1967 by the Ice-
landic Heart Association. The AGES-Reykjavik study was a
follow-up study designed to examine risk factors, including
genetic susceptibility and gene/environment interaction, in
relation to disease and disability in old age. Data measure-
ments were performed during 2002–2006 and included
blood draws, electrocardiograms, anthropometry (BMI),
and measures of psychological and physical function [18].
Additionally, the AGES-Reykjavik study also had childhood
(age 8–13 years) anthropometric measures from 2120 par-
ticipants from the 2 main schools in Reykjavik [19]. Data
from school records were only available from 1929 and
onwards which means that no growth data was available
for 8-year olds born before 1921 (i.e. aged over 81 during
AGES-Reykjavik study). The childhood anthropometric
data was thus gathered for children who were 8–13 during
1929–1947 (Fig. 1).
For this analysis we selected AGES-Reykjavik partici-
pants who had childhood anthropometric measurements
available at age 8 or 13 years (n = 938) and who had BMI
data at late-life. An additional 49 individuals were ex-
cluded due to missing values on late-life mental health,
leaving 889 participants for the main analyses.
Measures
Anthropometric data
Childhood and adolescent growth measurements were
extracted from archived school records. Yearly child-
hood weight and height measurements taken by a
trained school nurse were available from ages 8 to 13
years. For this analysis we chose to use the weights and
heights from age 8 and 13 years (referred to as childhood
weight) as it gives a spread in age. BMI was used as a
continuous variable and categorized into normal and
overweight/obese. The use of BMI as a categorical vari-
able was primarily because we expected the relationship
between BMI and depression to be non-linear. However
the use of BMI as a continuous variable has the advan-
tage of providing more statistical power. To make an-
thropomorphic data at different ages comparable, BMI
in childhood/adolescence was translated to BMI at age
18 years using the sex and age (in half year intervals)
specific BMI cut-offs of the paper of Cole et al. [20].
Subsequently, BMI categories were made. Initially, three
categories were made (normal, thin and overweight/
obese) that correspond to underweight (BMI < 18 kg/m2)
normal weight (BMI ≥18,< 25 kg/m2) and overweight or
obese (BMI ≥ 25 kg/m2) classes at age 18, however as
there was no difference between the thin and normal
group these two groups were combined. Thus, for a girl
aged between 7.5 and 8 years a BMI of 18.03 kg/m2
translates to a BMI of 25 kg/m [2] at age 18 years, and is
therefore classified as overweight/obese, whereas for a
boy of the same age this would be a BMI of 18.16 kg/m2.
Late-life weight and height were assessed during the
AGES-Reykjavik clinical examination (2002–2006). Par-
ticipants’ height was measured to the nearest 0.5 cm and
weight to the nearest 0.1 kg, in subjects without shoes
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and in light undergarments. BMI was calculated and
categorized according to the World Health Organisation
(WHO) classifications: < 25 kg/m2 (normal/ underweight),
25 to < 30 kg/m2 (overweight), ≥ 30 kg/m2 (obese).
Depression
Late-life depressive symptoms were assessed during the
AGES-Reykjavik data collection by using the 15-item
version of the Geriatric Depression Scale (GDS) trans-
lated into Icelandic [21, 22]. The score was used con-
tinuously and was also dichotomized with a score of ≥5
indicating depressive symptoms [23].
The presence of lifetime major depressive disorder
(MDD) was assessed at late-life during the AGES-Reykjavik
data collection (2002–2006) according to the Diagnostic
and Statistical Manual of Mental Disorders (DSM)-IV [24]
criteria using the Mini International Neuropsychiatric
Interview (MINI) [25]. The MINI is a short diagnostic tool
designed to generate a diagnosis for depression and has
been validated to yield a reliable DSM-IV diagnosis [26].
To ensure reliable answers, only individuals with no diag-
nosis of dementia or a score of > 21 on the Mini-mental
state examination (MMSE) [27] were eligible to receive the
MINI, those who had dementia or a score of > 21 were
excluded from the analysis. For efficiency, a preselected
group completed the MINI. Individuals were selected if
they (i) had a GDS score ≥ 6 or (ii) had a GDS score of 4 or
5 and a positive response to 3 out of the 4 following anxiety
questions “In the past month, have you felt anxious or
frightened?”; “Were there times lately that you felt anx-
ious?”; “Are there special situations that make you anx-
ious?”; “Have you ever had attacks of fear or panic?”, or (iii)
if they reported ever to have had a doctor diagnosis of de-
pression, or (iv) reported previous use of antidepressant
medications, or (v) were currently using antidepressant
medication as evidenced from medication bottles brought
to the interview. Based on the MINI, individuals were clas-
sified as “ever” versus “never” having MDD to create the
variable lifetime MDD. Those classified as ever having
MDD were asked at what age they first had symptoms.
Covariates
Covariates were assessed at late-life during the AGES-
Reykjavik data collection. They were selected a priori
based on findings from other studies. We considered
level of education attained (primary, secondary, college,
university), smoking habits (never, former, current), al-
cohol consumption (grams/week) and current amount of
Fig. 1 Flow diagram of data collection
Gibson-Smith et al. BMC Pediatrics           (2020) 20:25 Page 3 of 9
physical activity (never, rarely, occasionally, moderate,
high) as potential confounders.
Statistical analysis
For continuous variables the population was described
using means and standard deviations (SD); or medians
and interquartile ranges for non-normally distributed
variables. Percentages were used to describe categorical
variables.
Logistic regression analysis was used to estimate the
odds ratios for late-life depressive symptoms using the
dichotomized GDS score in relation to childhood and
adolescent BMI (kg/m2) or BMI categories (under-
weight/normal weight vs. overweight/obesity). Three
models were made: the first adjusted for sex and the sec-
ond additionally included late-life lifestyle factors (edu-
cation, current physical activity, smoking and alcohol
use). The third model additionally included BMI during
late-life. Additionally, linear models were made using a
continuous logarithmic GDS score (GDS score was not
normally distributed) and BMI (kg/m2), adjusted for sex.
Logistic regression models with adjustments for sex
(model 1) and lifestyle variables (model 2) were used to
estimate the relationship of BMI at age 8 and 13 years
with lifetime MDD (yes/no). In order to eliminate re-
verse causality, those who had developed MDD before
the age of 13 years (n = 3) were excluded from the MDD
analysis. Missing data among the covariates was small
(≤3%) and was therefore ignored (e.g. available case ana-
lysis). Participants with no anthropometric data were ex-
amined to see if their sociodemographic charicteristics
and late-life depressive symptoms significantly differed
from those who did have anthropometric data. Analysis
were conducted in SPSS version 23 (Inc., Chicago, Illi-
nois, USA) and statistical significance was set at P < 0.05.
Results
A total of 889 individuals who had complete late-life
GDS data and childhood BMI information available for
either age 8 (n = 664) or age 13 (n = 711) from school
record dating back to1929–1947 were included. Those
excluded from this analysis due to lack of childhood/
adolescence anthropometric data (i.e. participants from
the AGES-Reykjavik study who did not attend one of the
two schools in Reykjavik from where the childhood/ado-
lescence data were obtained), had significantly lower
late-life GDS scores and were slightly older than those
eligible for inclusion. From the included individuals 101
(11.2%) had a late-life GDS ≥5 and 36 (4.1%) had a life-
time MDD with an onset after age 13 years (39 (4.4%
after age 8 years). The median GDS score was 2 (inter-
quartile range 1–3). The average self-reported age of
MDD onset was 43.5 years (standard deviation (SD)
20.2). Just over half were female and the average age at
which they attended the AGES-Reykjavik study measure-
ment was 74.9 years (SD 4.5) (Table 1). Only a few per-
sons were overweight or obese at age 8 or 13 years (n =
23, 3.5% and n = 26, 3.7%, respectively). During adult-
hood this number rose markedly, with 68.4% being over-
weight or obese by late-life.
Childhood/adolescent BMI & late- depressive symptoms
BMI at age 8 or 13 years was not associated with having
current late-life depressive symptoms using a GDS cut-
off of ≥5 (Odds Ratio [OR] 0.99 95% confidence interval
Table 1 Descriptive characteristics of the Reykjavik-AGES sample
at late-life (age ~ 75y) with historical anthropometric data
Total population (N = 889)
Age (years) mean (SD) 74.9 (4.5)









Alcohol intake (g/week), median [IQR] 3.2 [0–16]




BMI late life (age ~ 75) (kg/m2), mean (SD) 27.5 (4.6)




GDS score (age ~ 75), median [IQR] 2.1 [1–3]
GDS score≥ 5 n, % 33 11.2
Lifetime MDD n, % 4.4
BMI age 8 (kg/m2), mean (SD) 15.9 (1.2)
BMI categories age 81 n, %
Normal/Underweight 641 96.5
Overweight/obese 23 3.5
BMI age 13 (kg/m2), mean (SD) 18.3 (2.1)
BMI categories age 131 n, %
Normal/Underweight 685 95.3
Overweight/obese 26 3.7
BMI Body Mass Index, GDS Geriatric depression scale, MDD Major depressive
disorder, SD standard deviation, IQR Interquartile range.
1Based on cut-offs from Cole et al., (2000)
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[CI] 0.81–1.21 and OR: 0.94 CI: 0.84–1.06 respectively)
(Table 2). Similarly, no significant relationships were
found in being overweight/obese at age 8 or 13 years
(compared to normal BMI) with current late-life depres-
sive symptoms. Adjustment for life-style factors or BMI
during late-life did not change these results. Similar re-
sults were found when the GDS was used as a continu-
ous score as neither BMI at age 8 or 13 years were
significantly associated with the GDS score (β: -0.07 95%
CI: − 0.05, 0.03, β: -0.06 95% CI: − 0.03, 0.02 (sex ad-
justed) respectively (data not shown)).
Childhood/adolescent BMI & lifetime MDD
After adjustment for sex, a modest but non-statistically
significant association was observed between BMI at age
8 and 13 years and increased risk of lifetime MDD (OR:
1.15; CI:0.88–1.50, OR:1.14; CI: 0.98–1.32 respectively)
(Table 3). Being overweight or obese at age 8 was associ-
ated with increased risk of lifetime MDD (OR: 4.30; CI:
1.34–13.76) when compared to having a normal BMI.
Although the odds ratio of lifetime MDD was also
elevated for being overweight or obese at age 13 years
(OR = 3.00) this did not reach statistical significance. Ad-
justment for late-life lifestyle factors slightly attenuated
the odds ratios (e.g. OR for lifetime MDD 4.03 CI 1.16–
13.96 for overweight or obesity at age 8 compared to
normal BMI).
Discussion
This study reports on measured childhood/adolescence
BMI with follow-up depression data more than 60 years
later. Our findings show that being overweight or obese
during childhood/adolescence is not associated with
depressive symptoms during late-life. However, being
overweight at age 8 (and possibly age 13 years) was asso-
ciated with a significant increased risk of lifetime MDD.
However, our results must be taken with caution due to
the low prevalence of overweight/obese at young age
and the low prevalence of participants with lifetime
MDD in this cohort.
Only one other study has compared childhood/adoles-
cent overweight/obesity with depressive symptoms dur-
ing late-life in 4410 participants. The study found that
women who were overweight in adolescence were sig-
nificantly more likely to experience depressive symptoms
at age 65 than their normal weight counterparts, al-
though no relationship was observed for men [6]. This
was not confirmed in our results, as we found no associ-
ations between childhood and adolescent obesity and
late-life depressive symptoms. Differences between the
two studies may be that we used measured childhood
weight and height to obtain BMI, and the comparative
study used a relative BMI based on high school photos
(age 14–18). Also, the age at which BMI was measured
in our study was slightly younger. Further, our small
sample size, preventing us from performing an analysis
stratified by sex, could also explain the differences. An-
other important point is that we assessed late-life de-
pression at age 66–86, which is on average 10 years
older than the comparative study, increasing the risk of
other important factors which may contribute to current
depressive symptoms such as chronic disease, frailty,
poor physical functioning and sleep disturbance [28, 29].
Our study found that being overweight at age 8 and 13
is associated with an increased risk of lifetime MDD, al-
though only the odds for age 8 reach statistical signifi-
cance. Comparison to other studies is difficult as the age
ranges and follow-up durations used are varied. Three
other studies found significant associations between child-
hood/adolescence obesity (measured at ages 9–18 years, 5
years and 7–15 years, respectively) and a DSM based diag-
nosis of depression 20–30 years later [9, 14, 30]. However,
in one of these studies statistical significance was only ap-
parent in females but not in males. Interestingly, studies
Table 2 Association between childhood BMI with late-life depressive symptoms1 in an Icelandic population (N = 889)
Late-life depressive
symptoms (cases/n)
Model 12 Model 23 Model 34
Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value
Continuous BMI
BMI age 8 (kg/m2) 69/664 0.99 (0.81–1.21) 0.91 0.98 (0.79–1.20) 0.81 0.97 (0.78–1.20) 0.76
BMI age 13 (kg/m2) 84/711 0.94 (0.84–1.06) 0.31 0.95 (0.85–1.07) 0.43 0.95 (0.83–1.07) 0.37
BMI categories
Normal or underweight age 8 66/641 1.00 (reference) 1.00 (reference) 1.00 (reference)
Obese or overweight age 8 3/23 1.12 (0.32–3.90) 0.86 0.95 (0.26–3.52) 0.94 0.95 (0.25–3.49) 0.93
Normal or underweight age 13 82/685 1.00 (reference) 1.00 (reference) 1.00 (reference)
Obese or overweight age 13 2/26 0.59 (0.14–2.53) 0.47 0.61 (0.13–2.72) 0.51 0.59 (0.13–2.65) 0.49
BMI Body mass index, GDS Geriatric depression scale, CI Confidence intervals.
1 GDS score ≥ 5 measured at age ~ 75 y
2 Model 1 = adjusted for sex
3 Model 2 = Model 1 + education, physical activity, smoking status and alcohol use at late-life
4 Model 3 = Model 2 + BMI at late-life
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that do not take a lifetime approach, i.e. with very short
follow-up periods, tend to find no relationship between
childhood or adolescent obesity (ages 11–17) and subse-
quent MDD [13, 31]. The lack of significant associations
between childhood obesity and MDD onset in these stud-
ies could be explained by the very short follow-up periods
(1–4 years). A meta-analysis has also observed that stron-
ger associations between adolescence obesity and depres-
sion were found with longer follow-up periods (more than
10 years) [8]. It may be that the duration of the exposure
to obesity is of relevance to the development of depression
or that a longer time period is required for childhood
obesity to have an effect on a psychiatric diagnosis. Our
lack of findings between overweight and obesity at age 13
with lifetime MDD is most likely due to the insufficient
numbers of obese/overweight 13 year olds developing
MDD. Our cohort had a particularly low prevalence of
overweight/obese children (3.7% at age 13).
Our study focuses on the critical period of childhood
when the relationship between obesity and depression
may develop. This relationship is complex and many
mechanisms have been proposed. One of the most
widely proposed mechanism linking childhood obesity to
subsequent depression is low self-esteem which is fre-
quently observed in those who do not conform to the
cultural ideal body weight [32]. Low self-esteem has
been associated with subsequent depression [10]. Fur-
thermore, overweight children are more frequently sub-
jected to bullying which can also lead to increased stress
[33]. The impact of body dissatisfaction on self-esteem
during adulthood could be less than in younger ages,
and adult bullying is also less common. Another possi-
bility is that the shared vulnerability for both overweight
and depression is due in part to a shared genetic risk
[12]. One study indicated that 12% of the genetic com-
ponent of depression is shared with obesity [34], and an
even more recent genome-wide association study has
suggested genetic risk for MDD is correlated with body
mass [35]. Furthermore, it has been suggested that phys-
ical inactivity and an unhealthy diet may not only impact
depression via obesity but that an unhealthy lifestyle
may have an additive effect over and above the obese
status [36].
Alternatively, metabolic dysregulation resulting from
the cumulative long term exposure of an unhealthy BMI
could partly explain the association between BMI and
depression. Inflammation is a factor common to both
obesity and depression, although it has been suggested
that obesity and inflammation are outcomes of adoles-
cent depression, rather than contributing causes [37].
Alternatively, resistance to leptin may constitute a risk
for depression. Leptin is a hormone produced in propor-
tion to fat mass which controls appetite and energy ex-
penditure. Leptin also has an impact on mood. Animal
models have shown that peripheral and central adminis-
tration of leptin produces antidepressant-like effects.
Leptin resistance, a characteristic of severe obesity
(BMI ≥ 35 kg/m2), due to impaired leptin transport
across the blood–brain barrier, reduces the function of
leptin receptors, and defects in leptin signal transduction
[38]. Finally, overweight and obesity over the long term
are risk factors for somatic diseases which themselves
are associated with poorer mental health. There is no
simple pathway from body weight to depression. Most
likely, a combination of factors will play a role.
The strengths of this study are the long-term follow-
up enabling us to adopt a life-course approach to weight
and depression. We used measured height and weight,
also at childhood age, and we had two different mea-
sures of depression, depressive symptoms at late-life and
a clinical diagnosis of past depression, both measured
late-life. However, there are also some limitations. The




Model 12 Model 23
Odds Ratio 95% CI P-value Odds Ratio 95% CI P-value
Continuous BMI
BMI age 8 (kg/m2) 32/664 1.15 (0.88–1.50) 0.32 1.11 (0.84–1.47) 0.46
BMI age 13 (kg/m2) 30/708 1.14 (0.98–1.32) 0.10 1.12 (0.96–1.32) 0.14
BMI categories
Normal or underweight age 8 24/641 1.00 (reference) 1.00 (reference)
Obese or overweight age 8 4/23 4.304 (1.34–13.76) 0.01 4.034 (1.16–13.96) 0.03
Normal or underweight age 13 27/683 1.00 (reference) 1.00 (reference)
Obese or overweight age 13 3/25 3.00 (0.84–10.73) 0.09 2.65 (0.69–10.26) 0.16
BMI Body mass index, MDD Major Depressive Disorder, GDS Geriatric depression scale, CI Confidence intervals.
1 measured at age ~ 75 y
2 Model 1 = adjusted for sex
3 Model 2 = Model 1 + education, physical activity, smoking status and alcohol use
4 Significant at P-value <0.05
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main limitation was the low prevalence of overweight/
obesity (3.5% at age 8, 3.7% at age 13 years) and lifetime
MDD (4.4%). Current Icelandic statistics on obesity
show that 23% are overweight at age 9, and 22% are
overweight or obese at age 13 years [39]. The low preva-
lence of childhood overweight and obesity is partly a re-
sult of birth cohort differences. During the 1920’s-40’s
overweight and obesity would more likely be a result of
genetic vulnerability than environmental influences [40].
The low prevalence of lifetime MDD compared to
current estimates of 15–25% [41] has previously been
noted in this cohort [42]. The prevalence of MDD and
current depressive symptoms may be lower because
current depression is a risk factor for non-response and
for earlier mortality. Furthermore those with a MMSE
score < 21 were excluded, and given that depression and
dementia/mild cognitive impairment are highly comor-
bid [43], there is an increased likelihood that depressed
persons were excluded. The low number of participants
having lifetime MDD is partly reflective of the era into
which they were born. Unlike in the majority of Euro-
pean countries and in Northern America, depression
was not given much attention in Iceland until the 1980’s
by which time these participants would already be mid-
dle aged. However, assuming childhood overweight is as-
sociated with MDD, the low prevalence of childhood
overweight may partly explain the low prevalence of
MDD. The consequence of such a low prevalence means
that this study was poorly powered and the risk esti-
mates could be inflated. However, as the findings are
biologically plausible and for the most part confirmed by
other studies, we assume the general direction of associ-
ation to be true. Additionally, there were insufficient
data to explore the previously reported modifying effect
of sex for MDD or whether childhood overweight/obes-
ity was related to an earlier onset of MDD. Another
limitation is that we had no data on change in covariates
or childhood covariates, such as parental education of
social economic status, the latter of which is associated
with both depression and BMI. Examining life-long
MDD retrospectively from age 75 may be limited by the
fact that the recall period is long. Finally, this study
could be subject to a selection bias (those with poor
health such as high obesity and depression) may not sur-
vive up to age 75, or to increased rates of non-response,
which may have caused an underestimation of the true
associations.
Conclusion
Within this Icelandic sample, being overweight/obese
during childhood is associated with lifetime MDD, but
no associations were observed with late-life depressive
symptoms. The low prevalence of childhood overweight
in our data reflects the time period the study was
conducted. Given that more adolescents are obese today
than previously, understanding the mechanisms of the
associations between childhood obesity and depression
in later life will be of great importance. Our research im-
plies that childhood weight is an important determinant
of subsequent adult mental health and therefore studies
examining childhood obesity and lifetime MDD in popu-
lations where childhood obesity is more prevalent are
warranted.
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